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Early and Five-year Amputation and Survival Rate of Diabetic Patients
with Critical Limb Ischemia: Data of a Cohort Study of 564 Patients
Faglia E., Clerici G., Clerissi J., Gabrielli L., Losa S., Mantero M., Caminiti
M., Curci V., Lupattelli T., Morabito A.. Eur J Vasc Endovasc Surg
2006;32:484-90.
Objective To evaluate the early and late major amputation and survival
rates and related risk factors in diabetic patients with critical limb ischemia
(CLI).
Design Retrospective study.
Methods Revascularization feasibility, major amputation, survival rate
and related risk factors were recorded in 564 diabetic patients consecutively
hospitalized for CLI from 1999 to 2003 and followed until June 2005.
Results Peripheral angioplasty (PTA) was carried out in 420 (74.5%),
bypass graft (BPG) in 117 (20.7%) patients. In 27 (4.8%) patients both PTA
and BPG were not possible. Twenty-three above-the-ankle amputations
(4.1%) were performed at 30 days: 6 in PTA patients, 3 in BPG patients, 14
in non revascularized patients. In the follow-up of 558 patients (98.9%), 62
repeated PTAs and 9 new BPGs, 32 new major amputations (16 in PTA
patients, 14 in BPG patients and 2 in non-revascularized patients) were
performed. Major amputation was associated with absence of revasculariza-
tion (OR 35.9, p0.001, CI 12.9–99.7), occlusion of each of the three
crural arteries (OR 8.20, p0.022, CI 1.35–49.6), wound infection (OR
2.1, p0.004 CI 1.3–3.6), dialysis (OR 4.7, p0.001 CI 1.9–11.7) increase
in TcPO2 after revascularization (OR 0.80, p0.001 CI 0.74–0.87).
One hundred seventy three patients died during follow-up and this was
associated with age (HR 1.05, p0.001 CI 1.03–1.07), history of cardiac
disease (HR 2.16, p0.001 CI 1.53–3.06), dialysis (HR 3.52, p0.001 CI
2.08–5.97), absence of revascularization (HR 1.68, p0.001, CI 1.29–
2.19) and impaired ejection fraction (HR 1.08, p0.001, CI 1.05–1.09).
Conclusions In diabetic patients with CLI the revascularization is
feasible in most cases and allows a low rate of early major amputation. This
rate is higher in the follow-up period. Major amputation is very high in
patients where revascularization is not feasible while the high mortality rate
is due to the serious comorbidities observed in these patients.
Prognostic Significance of Raised Cardiac Troponin T in Patients
Presenting with Acute Limb Ischaemia
Rittoo D., Stahnke M., Lindesay C., Grocott E., Hickey N., Downing R..
Eur J Vasc Endovasc Surg 2006;32:500-03.
Objective To study the relation between serum cardiac troponin T
(cTnT) and mortality in patients presenting with acute limb ischaemia
secondary to an embolism.
Material and methods A two years prospective study of all patients
admitted to the vascular unit with a diagnosis of acute limb ischaemia
secondary to an embolism. On admission all patients had an ECG. A blood
sample was taken for measurement of cTnT, CRP, serum biochemistry, full
blood count and clotting. All embolectomies were performed under local
anaesthesia. Patients were followed until discharge from hospital and up to
twelve months after surgery.
Results There were 37 patients with lower limb and 2 patients with
upper limb ischaemia. Twenty four patients were female and fifteen were
male, with the mean age of 76 years (50–95) for women and 84 years
(77–90) for men. Seventeen patients (44%) had a raised cTnT. The patients
with raised cTnT were older than those with normal cTnT [86y (77–92) vs
77y (51–95), p0.01, t test]. The mean cTnT was 0.20 g/L (range:
0.11–0.27). Only two patients with raised cTnT gave a history of chest
pains. All of the patients with an elevated cTnT had also raised CRP. There
was no significant difference in the serum creatinine in the group of patients
with elevated cTnT compared to those with normal cTnT [112 mol/L
(range 98–159) vs 119 mol/L (range: 47–177), pns]. The cumulative
survival for cTnT patients at 7 days was 53% and that of cTnT patients
was 100%. The cumulative survival for cTnT and cTnT patients was
statistically different (p0.0000, 213.1, Log Rank test). Using regres-
sion analysis, an elevated cTnT was found to be an independent predictor of
outcome.
Conclusion A significant proportion of patients presenting with an
acutely ischaemic limb have an elevated cTnT. An elevated cTnT may be an
early marker of overall disease severity and a predictor of outcome.
A Randomised Trial of Endovascular and Open Surgery for Ruptured
Abdominal Aortic Aneurysm – Results of a Pilot Study and Lessons
Learned for Future Studies
Hinchliffe R.J., Bruijstens L., MacSweeney S.T.R., Braithwaite B.D.. Eur J
Vasc Endovasc Surg 2006;32:506-13.
Introduction EVAR has the potential to improve outcome after
ruptured abdominal aortic aneurysm (AAA). Published series have been
based upon selected populations.
Methods An interim analysis of a single centre prospective randomised
controlled trial comparing endovascular aneurysm repair (EVAR) with open
aneurysm repair (OAR) in patients with ruptured AAA was performed.
Patients who had a ruptured AAA and who were considered fit for open
repair were randomised to EVAR or OAR after consent had been obtained.
Those in the EVAR group had pre-operative spiral computed tomographic
angiography (CTA). The primary endpoint was operative (30-day) mortality
and secondary endpoints were moderate or severe operative complications,
hospital stay and time between diagnosis and operation. A power study
calculation required 100 patients to be recruited.
Results Between September 2002 and December 2004, 103 patients
were admitted with suspected ruptured AAA. Only 32 patients were re-
cruited to the study. Of these, four patients died before receiving surgical
treatment. On an intention to treat basis the 30-day mortality rate was 53%
in the EVAR group and 53% in the OAR group. Moderate or severe
operative complications occurred in 77% in the EVAR group and in 80% in
the OAR group. Median total hospital stay in the EVAR group was 10 days
(inter-quartile range 6–28) and 12 days (4–52) in the OAR group. Median
time between diagnosis and operation was 75 minutes (64–126) in the
EVAR group and 100 minutes (48–138) in the OAR group.
ConclusionsDespite the relative high operative mortality in the EVAR
group, these preliminary results show that it is possible to recruit patients to
a randomised trial of OAR and EVAR in patients with ruptured AAA. CT
scanning does not delay treatment.
The Mid-term Effect of Bare Metal Suprarenal Fixation on Renal
Function Following Endovascular Abdominal Aortic Aneurysm Repair
Davey P., Rose J.D., Parkinson T., Wyatt M.G.. Eur J Vasc Endovasc Surg
2006;32:516-22.
Objective The aim of this study was to assess the mid term effect of
proximal bare metal fixation design on renal function in patients undergoing
endovascular repair (EVR) of abdominal aortic aneurysm (AAA).
Methods Consecutive EVR patients for AAA from December 1995-
2001 were included and grouped to either infrarenal (Group 1) or uncov-
ered suprarenal (Group 2) fixation. Peri-operative renal function and at 6, 12
and 24 months was determined by serum creatinine (sCr mmoll1) and
Cockroft-Gault creatinine clearance (CrC mlmin1). Changes in renal func-
tion were compared using non-parametric analysis.
Results Of the 179 EVR procedures during this six-year period, paired
renal data was available for 135 patients at a minimal follow-up of 6 months
(Gp1, n63; Gp2, n72). Median pre-EVR sCr and CrC were 113, 57 in
Group 1 and 108, 58 in Group 2, pNS. There was no significant deterio-
ration in renal function within or between either group at 2 years post-EVR:
median sCr, CrC values were 118, 56 (Group 1) and 111, 56 (Group 2), all
pNS.
Conclusion This study suggests mid-term renal function remains
unaffected following EVR of AAA, irrespective of proximal fixation type.
Designs to improve stent durability and EVR applicability do not appear to
compromise renal function.
Duplex Ultrasound Scanning is Reliable in the Detection of Endoleak
Following Endovascular Aneurysm Repair
Sandford R.M., Bown M.J., Fishwick G., Murphy F., Naylor M., Sensier Y.,
Sharpe R., Walker J., Hartshorn T., London N.J., Sayers R.D.. Eur J Vasc
Endovasc Surg 2006;32:537-41.
Objective To investigate the value of duplex ultrasound scanning
(DUSS) in the routine follow up of patients following EVAR.
Methods Imaging was reviewed for 310 consecutive patients under-
going EVAR at a single centre. Concurrent ultrasound and CT scans were
defined as having occurred within 6 months of each other. There were 244
paired concurrent DUSS and CT scans which were used for further analysis.
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These modalities were compared with respect to sensitivity, specificity,
positive and negative predictive values and level of agreement (by Kappa
statistics) using CT as the ‘gold standard’.
Results DUSS failed to detect a number of endoleaks which were seen
on CT and the sensitivity of this test was therefore poor (67%). However, the
specificity of DUSS compared more favourably with a value of 91%. Positive
predictive values ranged from 33–100% but negative predictive values were
more reliable with values of 91–100% at all time points post operatively.
There were no type I leaks, or endoleaks requiring intervention which were
missed on DUSS. Overall, there was a ‘fair’ level of agreement between the
two imaging modalities using Kappa statistics.
Conclusion Although DUSS is not as sensitive as CT scanning in the
detection of endoleak, no leaks requiring intervention were missed on DUSS
in this study. DUSS is much cheaper than CT and avoids high doses of
radiation. DUSS therefore remains a valuable method of follow up after
EVAR and can reduce the need for repeated CT scans.
Fresh Arterial Grafts as Conduits for Vascular Reconstructions in
Transplanted Patients
Matia I., Adamec M., Janousek L., Lipar K., Viklicky O.. Eur J Vasc
Endovasc Surg 2006;32:549-56.
Objectives To assess the outcome of arterial allografts in patients
receiving organ transplantation.
Design From October 1997 to June 2005, we used fresh arterial
allografts as vascular conduits in 21 patients for the treatment of claudica-
tions (10), abdominal aortic aneurysm (6), complicated renal transplanta-
tion (2), acute lower extremity ischemia (2) and gangrene (1). At the time of
the vascular procedure, ten of the patients (Group A) had already undergone
organ transplantation. The mean follow up period was 32 months for renal
and 37 months for heart recipients, respectively. In 11 patients (Group B),
the vascular reconstruction was undertaken simultaneously with the renal
transplantation. The mean follow up period was 49 months.
Results There was no arterial allograft related deaths. No signs of
arterial graft infection or requirement for secondary intervention (angio-
plasty and/or thrombolysis) were observed during the follow up period.
Conclusions Our experience suggests that it is possible to use fresh
arterial allografts in the treatment of arterial occlusive disease or abdominal
aortic aneurysm, both in already transplanted patients and simultaneously
with organ transplantation, with good results.
High Risk Plaque, High Risk Patient or High Risk Procedure?
Naylor A.R., Golledge J.. Eur J Vasc Endovasc Surg 2006;32:557-60.
SAPPHIRE, a randomised trial of endarterectomy versus angioplasty in
’high-risk’ patients, concluded that angioplasty was ’not inferior’ to surgery.
This has subsequently been translated to mean that angioplasty was ’prefer-
able’ or ’advisable’ in patients considered high-risk for surgery, with no
further discrimination between symptomatic and asymptomatic individuals.
Moreover, there have been suggestions that the accepted procedural risks
may have to be increased in these patients. In fact, 71% of patients in
SAPPHIRE were asymptomatic in whom there was an average 6% 30-day
death/stroke rate. At this level of risk, neither surgery nor angioplasty could
ever prevent long-term stroke. The concept of identifying high-risk patients
is laudable, but they should be high risk for stroke (i.e. symptomatic). There
is currently little systematic evidence to include asymptomatic patients
within this definition.
Chronic Venous Disease Treated by Ultrasound Guided Foam
Sclerotherapy
Smith P. Coleridge. Eur J Vasc Endovasc Surg 2006;32:577-83.
Aim To report the outcome of a series of patients with chronic venous
disease due to incompetence of saphenous trunks managed by ultrasound
guided foam sclerotherapy (UFS).
Patients and methods A group of 808 patients comprise this series.
CEAP clinical class for limbs was C1: 15%, C2: 81%, C3: 0.5%, C4: 2%, C5:
0.2%, C6: 0.4%. UFS using 1% polidocanol (107 limbs), 1% sodium tetra-
decyl (102 limbs), 3% sodium tetradecyl (900 limbs) was employed to treat
incompetent saphenous trunks. In patients with unilateral varices 1 treat-
ment was required in 43% of patients and 2 treatments in 48% of patients to
obliterate incompetent saphenous trunks and varices. For bilateral varices 2
treatments were required in 40% of patients and 3 treatments in 46% of cases.
The clinical outcome and patency of treated veins on duplex ultra-
sonography was assessed at a mean follow-up interval of 11 months.
Results A total of 459 limbs were available for assessment at a fol-
low-up interval of 6 months or greater. The CEAP clinical stage was C0:182
limbs, C1: 241, C2: 22, C3: 0, C4: 11, C5: 2, C6:1. The GSV had remained
obliterated in 88% of limbs and the SSV in 82% of limbs. Recurrent venous
incompetence following previous surgery was as effectively treated by UFS as
primary incompetence.
Conclusions This technique is useful in the management of chronic
venous disease as an alternative to surgery.
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